Semi-Annual Statement Of Income

STELLA PHARMA CORPORATION - Filing #7248023

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual statement of income
Statement of income
Net sales
961,058,000 JPY
269,491,000 JPY
Gross profit (loss)
845,748,000 JPY
217,298,000 JPY
Ordinary profit (loss)
-137,869,000 JPY
-760,208,000 JPY
Selling, general and administrative expenses
935,995,000 JPY
977,598,000 JPY
Extraordinary losses
JPY
768,000 JPY
Selling, general and administrative expenses
Depreciation
17,025,000 JPY
13,613,000 JPY
Operating profit (loss)
-90,246,000 JPY
-760,300,000 JPY
Profit (loss) before income taxes
-137,869,000 JPY
-760,976,000 JPY
Income taxes - current
2,941,000 JPY
2,772,000 JPY
Non-operating income
11,648,000 JPY
4,624,000 JPY
Non-operating income
Interest income
598,000 JPY
11,000 JPY
Interest on securities
688,000 JPY
1,428,000 JPY
Income taxes
2,941,000 JPY
2,772,000 JPY
Non-operating expenses
59,271,000 JPY
4,533,000 JPY
Profit (loss)
-140,811,000 JPY
-140,811,000 JPY
-140,811,000 JPY
-140,811,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
-763,749,000 JPY
Non-operating expenses
Interest expenses
4,082,000 JPY
2,084,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.